Denver Post Broncos writer Ryan O’Halloran posts his Broncos Mailbag weekly during the season. You can pose a Broncos- or NFL-related question for the Broncos Mailbag here. Follow Ryan for more daily updates on Twitter. Ryan, what do you envision as the split for touches in the backfield: 50/50 for Royce Freeman and Devontae Booker? Is it only a matter of time before Freeman takes the job and runs with it? — Jeff, Alamosa I don’t envision a 50-50 split, but I agree with you that it’s a matter of weeks until Freeman takes over the main tailback role. The Broncos may start Booker as a semi-ceremonial nod against Seattle, but Freeman – with two touchdowns in two preseason games – has exhibited the kind of running style (can make a guy miss in the open field and can navigate his way in short-yardage situations) that should make him the No. 1. I do think Booker can carve out a third-down role, though. What win-loss record during the regular season could … [Read more...] about Broncos Mailbag: Royce Freeman or Devontae Booker — who’s Denver’s starting running back?
Starting running again
Updated 11:47 pm, Wednesday, June 27, 2018 Photo: Mark Henle, AP Image 1of/1 CaptionClose Image 1 of 1 FILE - In this June 14, 2018, file photo, Don Shooter testifies during a hearing in Maricopa County Superior Court in Phoenix. Shooter, the first state lawmaker in the nation to be first kicked out of office amid sexual misconduct claims since the #MeToo movement started, can run for state Senate, the Arizona Supreme Court ruled Wednesday, June 27. (Mark Henle/The Arizona Republic via AP, Pool, File) less FILE - In this June 14, 2018, file photo, Don Shooter testifies during a hearing in Maricopa County Superior Court in Phoenix. Shooter, the first state lawmaker in the nation to be first kicked out of office ... more Photo: Mark Henle, AP Court: Arizona lawmaker kicked out amid #MeToo can run again 1 / 1 Back to Gallery … [Read more...] about Court: Arizona lawmaker kicked out amid #MeToo can run again
PUBLISHED: 14:46 19 June 2018 Jason Butler of NW Brown. Picture: NW Brown. Archant Will Rolls Royce’s biggest transformation plan in nearly 20 years pay off, asks Jason Butler of NW Brown. Chief executive Warren East said an overcomplicated way of working was holding the 112-year-old engineering giant back, and a A six-month review revealed unnecessary complexities in processes and a lack of accountability and cost-awareness throughout the business. As a result, Mr East has announced that he will be implementing further restructuring in the business. He had already announced plans to consolidate the company into three focused business units - civil aerospace, defence and power systems, as opposed to the current five-unit structure. This is designed to remove management duplication, with each unit having more autonomy. Some 4,600 back office and middle-management jobs will be cut over the next two years, about two-thirds in the UK headquarters in Derby. The company needs … [Read more...] about Jason Butler of NW Brown: Will fresh cuts at Rolls Royce get the engine running again?
Scott Bauer, Associated Press Updated 3:35 pm, Wednesday, May 30, 2018 Photo: M.P. KING, AP Image 1of/1 CaptionClose Image 1 of 1 FILE- In this Nov. 11, 2013 file photo, Wisconsin Supreme Court chief justice Shirley Abrahamson questions state attorney general J.B. Van Hollen, during arguments in Madison Teachers Inc. vs. Scott Walker, in the Wisconsin Supreme Court at the state Capitol in Madison, Wis. Abrahamson, 84, the longest-serving Wisconsin Supreme Court justice in state history and the first woman to serve on the high court, said Wednesday, May 30, 2018, that she will not seek re-election next year, setting up a wide open race to replace her. (M.P. King /Wisconsin State Journal via AP, Pool, File) less FILE- In this Nov. 11, 2013 file photo, Wisconsin Supreme Court chief justice Shirley Abrahamson questions state attorney general J.B. Van Hollen, during arguments in Madison Teachers Inc. vs. … [Read more...] about Wisconsin Supreme Court Justice Abrahamson won’t run again
Published May 06, 2018 Markets Motley Fool Facebook Twitter Comments Print Shares of Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) created a high-water mark around three and a half years ago that's still 51% above recent prices. The drugs it outlicensed to its big pharma partner, Sanofi (NYSE: SNY), succeeded in the clinic. Unfortunately, commercial launches that take baby steps when investors expect giant leaps can pressure even a biotech's stock price no matter how productive its discovery engine may be. The past few years have been disappointing, but there are reasons to suspect the younger members of Regeneron's family of innovative drugs are about to start climbing in the quarters ahead. Let's begin with recent developments that could finally kick the Sanofi collaboration into high gear. Continue Reading Below 1. Praluent relaunch Heart disease is still the leading cause of death for men and women in the U.S. and uncontrolled cholesterol plays a big … [Read more...] about 3 Reasons Regeneron Stock Could Start Climbing Again